Zacks Research Issues Optimistic Outlook for CLB Earnings

Core Laboratories Inc. (NYSE:CLB – Free Report) – Research analysts at Zacks Research increased their Q4 2027 earnings per share estimates for shares of Core Laboratories in a research note issued on Wednesday, November 18th. Zacks Research analyst Team now expects that the oil and gas company will post earnings per share of $0.23 for the quarter, up from their prior estimate of $0.22. The consensus estimate for Core Laboratories’ current full-year earnings is $0.56 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2028 earnings at $0.26 EPS and Q2 2028 earnings at $0.32 EPS.

Core Laboratories (NYSE:CLB – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The oil and gas company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. Core Laboratories had a net margin of 3.42% and a return on equity of 8.94%. The business had revenue of $132.08 million during the quarter, compared to analysts’ expectations of $131.87 million. During the same period in the previous year, the company earned $0.22 earnings per share. Core Laboratories’s revenue for the quarter was down 1.8% on a year-over-year basis.

CLB has been the topic of a number of other reports. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings lowered shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, November 13th. Finally, Johnson Rice upgraded Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 price objective for the company in a research report on Thursday, August 13th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $21.00.

Get Our Latest Analysis on Core Laboratories

Core Laboratories Trading Down 7.8%

Shares of CLB stock opened at $7.75 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.60 and a current ratio of 2.19. The firm has a fifty day moving average of $9.95 and a 200-day moving average of $13.14. The stock has a market cap of $354.88 million, a price-to-earnings ratio of 20.38, a P/E/G ratio of 1.56 and a beta of 1.18. Core Laboratories has a 52-week low of $7.71 and a 52-week high of $20.36.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Monday, November 9th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 9th. Core Laboratories’s payout ratio is 10.53%.

Institutional Investors Weigh In On Core Laboratories

Hedge funds have recently bought and sold shares of the stock. State of Wyoming boosted its position in shares of Core Laboratories by 267.7% in the first quarter. State of Wyoming now owns 4,626 shares of the oil and gas company’s stock valued at $78,000 after acquiring an additional 3,368 shares during the period. Voya Investment Management LLC acquired a new position in Core Laboratories in the 3rd quarter valued at $98,000. Corient Private Wealth LP acquired a new position in Core Laboratories in the second quarter valued at about $141,000. The Manufacturers Life Insurance Company bought a new stake in shares of Core Laboratories during the 2nd quarter worth approximately $156,000. Finally, Fifth Third Bancorp boosted its holdings in shares of Core Laboratories by 2,397.6% in the 1st quarter. Fifth Third Bancorp now owns 11,414 shares of the oil and gas company’s stock valued at $192,000 after purchasing an additional 10,957 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

About Core Laboratories

(Get Free Report)

Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery.

Featured Stories

Earnings History and Estimates for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.